Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, PETERS WILLIAM J, holds the title of CFO, EVP & TREASURER at Amphastar Pharmaceuticals, Inc..
On 2026-11-16, the insider transacted 22,000 shares.The shares were transacted at a weighted average price of $23.99 per share, resulting in a total market-relevant value of $528K.
PETERS WILLIAM J (CFO, EVP & TREASURER) sold $528K of $AMPH
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.